[1] 甘远, 黄方华, 王瑞云,等. 幽门螺杆菌感染的治疗现状及进展[J]. 海南医学, 2016, 27(9): 1483-5. [2] Hunt R H, Xiao S D, Megraud F, et al. World Gastroenterology rganization. World Gastroenterology Organisation Global Guideline: Helicobacter pylori, in Developing Countries[J]. Journal of Gastrointestinal & Liver Diseases Jgld, 2011, 20(3):299-304. [3] Sezgin O, Barlas I O, Uçbilek E, et al. Modified sequential Helicobacter pylori eradication therapy using high dose omeprazole and amoxicillin in the initial phase in the extensive metaboliser Turkish patients for CYP2C19 polymorphism is ineffective[J]. Acta gastro-enterologicaBelgica,2014, 77(1):3-7. [4] Zhou Y Q, Xu L, Wang B F, et al. Modified Sequential Therapy Regimen versus Conventional Triple Therapy for Helicobacter Pylori Eradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative Study[J]. Gastroenterology Research & Practice, 2012, 2012(5):129-134. [5] Chul, Chung, Sung, et al. Dual-priming oligonucleotide-based multiplex PCR using tissue samples in rapid urease test in the detection of Helicobacter pylori infection[J]. World Journal of Gastroenterology, 2014, 20(21):6547-6553. [6] 储建坤, 崔东升, 朱秀芳,等. HpSA检查与14C尿素呼气试验检测幽门螺杆菌临床对比[J]. 中国老年学杂志, 2015, 35(2):315-316. [7] Weiss T, Schönfeld N, Otto-Knapp R, et al. Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains[J]. European Respiratory Journal, 2015, 45(1):285-287. [8] Lin Y F, Chen C Y, Tsai M H, et al. Duodenal ulcer-related antigens from Helicobacter pylori: immunoproteome and protein microarray approaches[J]. Molecular & Cellular Proteomics Mcp, 2007, 6(6): 1018-1026. [9] 郭庆红, 李强, 路红,等. 不同方案根除幽门螺杆菌的疗效比较[J]. 兰州大学学报(医学版), 2014, 40(1):62-65. [10] Giorgio F, Principi M, Francesco V D, et al. Primary clarithromycin resistance to Helicobacter pylori : Is this the main reason for triple therapy failure?[J]. World Journal of Gastrointestinal Pathophysiology, 2013, 4(3):43-46. [11] 付尚勤, 谢步善, 万伦常. 益生菌联合标准三联疗法治疗Hp阳性消化性溃疡的疗效[J]. 实用临床医药杂志, 2014, 18(13):111-112. [12] De Francesco V, Hassan C, Ridola L, er al. Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study[J]. J Med Microbiol, 2014, 63(5):748-752. [13] Vaira D, Zullo A, Vakil N, et al. Sequential Therapy versus Triple Therapy for Helicobacter pylori Eradication[J]. Helicobacter, 2007,12(4): 424. [14] Seddik H, Ahid S, El Adioui T, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study[J]. European Journal of Clinical Pharmacology, 2013, 69(9):1709-1715. [15] Uygun A, Kadayifci A, Yesilova Z, et al. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori, eradication:A 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia[J]. Journal of Clinical Periodontology, 2008, 30(2):154-158. [16] 张茹, 钱家鸣. 序贯疗法根除幽门螺杆菌[J]. 医学与哲学, 2009,30(18):13-16. [17] Tsay F W, Wu D C, Kao S S, et al. Reverse Sequential Therapy Achieves a Similar Eradication Rate as Standard Sequential Therapy for Helicobacter pylori, Eradication: A Randomized Controlled Trial[J]. Helicobacter, 2015, 20(1):71-77. [18] 廖妍, 白岚. H + -K + -ATP酶的分布及其抑制剂PPI的作用[J].广东医学, 2016, 37(9): 1397-1399. [19] 徐建峰. 埃索美拉唑、克拉霉素、阿莫西林联合治疗幽门螺杆菌阳性胃溃疡患者102例疗效观察[J]. 中国临床医生杂志,2015, 43(5):51-53. |